H1 Our client was planning a launch of a product within a new indication. To ensure they were targeting the right audience, they wanted to better understand the treatment landscape across a total of five indications. H1 delivered the top...
  • March 4, 2022
  • 0 Comment
Read More
H1 has worked with the top Pharmaceuticals and Life Sciences Companies to help them better understand the HCP Universe. Specifically, H1 clients were seeking to increase MSL engagement. In reviewing the work done across those organizations, H1 uncovered an interesting...
  • March 4, 2022
  • 0 Comment
Read More
LABCORP Mobile Clinical Services (MCS) uses a patient-centric approach to transforming clinical trials, allowing for a suite of clinical trial visit services to be conducted at any time, wherever the patient may be by using a centrally managed network of...
  • March 3, 2022
  • 0 Comment
Read More
LABCORP Traditionally, clinical trials follow a standardized format, whereby the participant in the trial must attend the clinical site or sites for the purposes of screening, enrollment, treatment administration and data collection. However, the rigid structure of a conventional clinical...
  • March 3, 2022
  • 0 Comment
Read More
LABCORP OncologyThere is a gap between the number of patients needed to participate in new cancer trials and the number who give consent to take part. Decentralized clinical trials (DCTs) are helping to address this gap by increasing the reach...
  • March 3, 2022
  • 0 Comment
Read More
LABCORP Abstract: While adoption/acceptance/use of Mobile Clinical Services (MCS) is growing /increasing in most regions around the world, a number of Asia-Pacific countries remain hesitant to commit to this new approach to clinical trials. This case study reviews Labcorp MCS...
  • March 3, 2022
  • 0 Comment
Read More
MONOCL External experts are sought-after advisors for life science companies, where they inform critical decisions along the entire product lifecycle of a drug. These experts use the knowledge and experience they acquired over the course of their careers to help companies...
  • October 13, 2021
  • 0 Comment
Read More
San Francisco, CA (December 9, 2020) – Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced that Clovis Oncology has selected Alucio’s Beacon as its scientific exchange platform. Beginning in January 2021, Beacon will be used by Clovis medical affairs...
  • October 13, 2021
  • 0 Comment
Read More
San Francisco, CA (November 10, 2020) -Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced the release of new features for Beacon’s mobile phone users. These enhancements optimize the user experience for meeting attendees participating in...
  • October 13, 2021
  • 0 Comment
Read More
San Francisco, CA (September 24, 2020) – Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, announced today that it has joined The Board Challenge (www.theboardchallenge.org) initiative created to improve the representation of Black directors in corporate US boardrooms. Companies...
  • October 13, 2021
  • 0 Comment
Read More